Leukemia

Alkylating agent linked to therapy-related leukemia

(HealthDay)—For patients treated for Hodgkin's lymphoma (HL), cumulative doses of alkylating agent (AA) is associated with the risk of therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS), ...

Jan 15, 2013
popularity 5 / 5 (1) | comments 0

Iclusig approved for rare leukemias

(HealthDay)—Iclusig (ponatinib) has been approved by the U.S. Food and Drug Administration to treat two rare forms of leukemia..

Dec 16, 2012
popularity not rated yet | comments 0

Latest Spotlight News

New diagnostic approach for autism in Tanzania

Autism is no stranger to the children of Tanzania. What is rare in the East African nation is access to clinical services, including reliable diagnosis and evidence-based treatments. There is no autism diagnostic ...